A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB

NCT02615639 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

BIOLOGICAL: HPDC-T cells & Entecavir
DRUG: Entecavir
DRUG: HPDC-T cells & IFN-a-2a
DRUG: IFN-a-2a
DRUG: HPDC-T cells & Telbivudine
DRUG: Telbivudine

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University

Collaborators

[object Object]